To explore the clinical significance of Plexin-B2 upregulation in glioma, we performed Kaplan-Meier survival analyses with the NCI/Rembrandt data platform (Fig. 2B and Table S1). This evidence concerns the gene PLXNB2 and central nervous system cancer.